Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder

Lignende værker

• Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”
  af: Yamanishi, Tomonori, et al.
  Udgivet: (2020)
• The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
  af: Tomonori Yamanishi, et al.
  Udgivet: (2015-06-01)
• The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
  af: Tomonori Yamanishi, et al.
  Udgivet: (2015-06-01)
• Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
  af: Al-Ghazo, Mohammed A., et al.
  Udgivet: (2011)
• Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
  af: Tannenbaum, Stacey, et al.
  Udgivet: (2020)